ProSharesLeveraged EquityCRCA · NYSE Arca

ProShares Ultra CRCL (CRCA)

Compare Leveraged & Inverse ETFs Compare with others

Price: $12.81; —30 Oct 2026
Assets: $98.6M; Total net assets
Expense ratio: 0.95%; Category 0.00%
Yield: 4.59%; Trailing distributions

1Y return: -88.6%-76.1%; Category -12.6%
3Y CAGR: —; Category 31.4%
5Y CAGR: —; Category 2.8%

Loading NAV history…

ProShares Ultra CRCL

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	-26.4%	+8.7%	-68.6%	-67.7%	-88.6%	—	—	—	-90.0%
Leveraged Equity average	-23.8%	-14.7%	-17.9%	-7.1%	-12.6%	31.4%	2.8%	9.4%	-20.3%
Difference	-2.6%	+23.4%	-50.7%	-60.6%	-76.1%	—	—	—	-69.8%

Holdings

This ETF publishes no holdings breakdown.

ETF details

Issuer: ProShares
Category: Equity · Leveraged Equity
Ticker: CRCA
Exchange: NYSE Arca
Inception: 6 Aug 2025 (1.2 years)
Structure: Exchange Traded Fund
Expense ratio: 0.95% (category 0.00%)
Holdings turnover: 0%
Distribution yield: 4.59%
Beta, 3 years: 0.00
Total net assets: $98.6M

Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other leveraged equity ETFs

Other ETFs in the Leveraged Equity category.

Compare Leveraged & Inverse ETFs